Search Results 781-790 of 16338 for melatonin receptor agonists

  1. Mayo Clinic

    Share · Tweet. See also. Abdominal aortic aneurysm · Acne · Actinic keratosis · Atrial septal defect (ASD) · Autoimmune pancreatitis · Back pain ...

  2. Sleep Restriction and Parental History of Hypertension - Mayo Clinic

    * Use of melatonin supplements or any other over-the-counter sleep aid * Moderate-to-severe sleep disordered breathing (apnea/hypopnea index, AHI ≥15) or ...

  3. Pediatrics Clinical Trials - Medical Professionals

    This will be accomplished by utilizing the the immunoSEQ Human T-cell Receptor Beta (hsTCB) Assay (Adaptive Biothechnologies) and the publicly available ...

  4. (Summit) A Study to Evaluate the Efficacy and Safety of CGT9486 Versus Placebo in Patients With Indolent or Smoldering Systemic Mastocytosis - Mayo Clinic

    − Histamine receptor type 1 (H1) antagonist; − Histamine receptor type 2 (H2) antagonist; − Cromolyn sodium; − Leukotriene receptor antagonist ...

  5. Doctors and departments - Mayo Clinic

    Mayo Clinic's major research programs in pulmonary, critical care and sleep medicine include basic, applied and translational activities to improve patient care ...

  6. Hematology - Clinical trials

    ... receptor (ER and PR) all negative], HER2 positive whatever the ER/PR status ... Avelumab In Combination Regimens That Include An Immune Agonist ...

  7. Doctors & Departments - Mayo Clinic

    Research. Mayo Clinic's Department of Psychiatry and Psychology continues to study the use of rTMS for teenagers with treatment-resistant depression.

  8. Netupitant and palonosetron (oral route) - Side effects & dosage - Mayo Clinic

    Description. Netupitant and palonosetron combination is used to prevent nausea and vomiting that is caused by cancer medicines (chemotherapy).

  9. Evaluation Of Efficacy Of Povetacicept In Adults With Immunoglobulin A Nephropathy (IgAN) - Mayo Clinic

    The purpose of this study is to evaluate the efficacy of povetacicept in adult participants compared with placebo in reducing proteinuria and preserving renal ...

  10. Neurology - Clinical trials

    ... receptor (ER and PR) all negative], HER2 positive whatever the ER/PR status,, and HER2 negative/ER positive), (5) advanced, unresectable colorectal cancer ...